Pneumonia Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Pneumonia Testing Market is segmented By Type (Consumable and Analyzer), Method Type, Technology, End-User and Geography

Pneumonia Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Pneumonia Testing Market Size

Pneumonia Testing Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 2.11 Billion
Market Size (2030) USD 2.94 Billion
CAGR (2025 - 2030) 6.93 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Pneumonia Testing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Pneumonia Testing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Pneumonia Testing Market Analysis

The Pneumonia Testing Market size is estimated at USD 2.11 billion in 2025, and is expected to reach USD 2.94 billion by 2030, at a CAGR of 6.93% during the forecast period (2025-2030).

Pneumonia testing market is growing at good rate as pneumonia is a life-threatening disease wherein testing helps the people to know in advance and further, they can be cured quickly. The major factor attributing to the growth of the market are rise in adoption of POC testing and development in the field of nucleic acid detection. Moreover, the awareness level is increasing day by day which results in early diagnosis, hence promoting the growth of pneumonia testing market.

In addition, pneumonia is found to be the major cause of death in children. For instance, in 2018 according to UNICEF, about 800000 children died due to pneumonia. Also, these diseases are more prevalent in South Asia and African countries. However, due to the limited detection capability and accuracy, the market is expected to be hampered to a certain extent.

Pneumonia Testing Industry Overview

Pneumonia Testing Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott, Bio-Rad Laboratories, Inc., bioMerieux SA, Thermo Fisher Scientific, Hologic, Inc, Meridian Bioscience, Quidel Corporation, BD and Curetis.

Pneumonia Testing Market Leaders

  1. Abbott

  2. Bio-Rad Laboratories, Inc

  3. bioMerieux SA

  4. Thermo Fisher Scientific

  5. Hologic, Inc

  6. *Disclaimer: Major Players sorted in no particular order
Pneumonia Testing Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Pneumonia Testing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Popularity of POC Testing
    • 4.2.2 Surge in Awareness Towards Early Diagnosis
    • 4.2.3 Increase in Government Expenditure on Healthcare
  • 4.3 Market Restraints
    • 4.3.1 Limited Detection Capability and Accuracy
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Consumable
    • 5.1.2 Analyzer
  • 5.2 By Method Type
    • 5.2.1 Immunodiagnostic
    • 5.2.2 Molecular Diagnostic
    • 5.2.3 Point-of-Care (POC) Testing
  • 5.3 By Technology
    • 5.3.1 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 5.3.2 Immunofluroscence
    • 5.3.3 Immunohistochemistry (IHC)
    • 5.3.4 Polymerase Chain Reaction (PCR)
    • 5.3.5 Others
  • 5.4 By End-user
    • 5.4.1 Hospitals
    • 5.4.2 Diagnostic Centers
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Bio-Rad Laboratories, Inc.
    • 6.1.3 BioMérieux SA
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Curetis
    • 6.1.6 Hologic Inc.
    • 6.1.7 Meridian Bioscience
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Quidel Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Pneumonia Testing Industry Segmentation

Pneumonia is a lung disease caused by bacteria, virus and fungi infections in which inflammation in the air sacs, or alveoli is occurred. Pneumonia Testing is segmented By Product Type, Method Type, Technology Type, End User and Geography.

By Product Type Consumable
Analyzer
By Method Type Immunodiagnostic
Molecular Diagnostic
Point-of-Care (POC) Testing
By Technology Enzyme-Linked Immunosorbent Assay (ELISA)
Immunofluroscence
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
Others
By End-user Hospitals
Diagnostic Centers
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Pneumonia Testing Market Research FAQs

How big is the Pneumonia Testing Market?

The Pneumonia Testing Market size is expected to reach USD 2.11 billion in 2025 and grow at a CAGR of 6.93% to reach USD 2.94 billion by 2030.

What is the current Pneumonia Testing Market size?

In 2025, the Pneumonia Testing Market size is expected to reach USD 2.11 billion.

Who are the key players in Pneumonia Testing Market?

Abbott, Bio-Rad Laboratories, Inc, bioMerieux SA, Thermo Fisher Scientific and Hologic, Inc are the major companies operating in the Pneumonia Testing Market.

Which is the fastest growing region in Pneumonia Testing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Pneumonia Testing Market?

In 2025, the North America accounts for the largest market share in Pneumonia Testing Market.

What years does this Pneumonia Testing Market cover, and what was the market size in 2024?

In 2024, the Pneumonia Testing Market size was estimated at USD 1.96 billion. The report covers the Pneumonia Testing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Pneumonia Testing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Pneumonia Testing Industry Report

Statistics for the 2025 Pneumonia Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pneumonia Testing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Pneumonia Testing Report Snapshots